1. Home
  2. GHRS vs UVSP Comparison

GHRS vs UVSP Comparison

Compare GHRS & UVSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GHRS
  • UVSP
  • Stock Information
  • Founded
  • GHRS 2018
  • UVSP 1876
  • Country
  • GHRS Ireland
  • UVSP United States
  • Employees
  • GHRS N/A
  • UVSP N/A
  • Industry
  • GHRS Biotechnology: Pharmaceutical Preparations
  • UVSP Major Banks
  • Sector
  • GHRS Health Care
  • UVSP Finance
  • Exchange
  • GHRS Nasdaq
  • UVSP Nasdaq
  • Market Cap
  • GHRS 874.0M
  • UVSP 865.0M
  • IPO Year
  • GHRS 2021
  • UVSP 1989
  • Fundamental
  • Price
  • GHRS $12.22
  • UVSP $30.70
  • Analyst Decision
  • GHRS Strong Buy
  • UVSP Hold
  • Analyst Count
  • GHRS 8
  • UVSP 2
  • Target Price
  • GHRS $30.63
  • UVSP $29.00
  • AVG Volume (30 Days)
  • GHRS 183.0K
  • UVSP 100.0K
  • Earning Date
  • GHRS 08-07-2025
  • UVSP 10-22-2025
  • Dividend Yield
  • GHRS N/A
  • UVSP 2.83%
  • EPS Growth
  • GHRS N/A
  • UVSP 12.33
  • EPS
  • GHRS N/A
  • UVSP 2.73
  • Revenue
  • GHRS N/A
  • UVSP $298,354,000.00
  • Revenue This Year
  • GHRS N/A
  • UVSP $12.42
  • Revenue Next Year
  • GHRS N/A
  • UVSP $4.67
  • P/E Ratio
  • GHRS N/A
  • UVSP $11.37
  • Revenue Growth
  • GHRS N/A
  • UVSP 4.09
  • 52 Week Low
  • GHRS $6.00
  • UVSP $22.83
  • 52 Week High
  • GHRS $20.50
  • UVSP $32.86
  • Technical
  • Relative Strength Index (RSI)
  • GHRS 37.28
  • UVSP 47.54
  • Support Level
  • GHRS $13.71
  • UVSP $30.82
  • Resistance Level
  • GHRS $14.59
  • UVSP $31.43
  • Average True Range (ATR)
  • GHRS 0.73
  • UVSP 0.68
  • MACD
  • GHRS -0.09
  • UVSP -0.09
  • Stochastic Oscillator
  • GHRS 4.62
  • UVSP 31.87

About GHRS GH Research PLC

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.

About UVSP Univest Financial Corporation

Univest Financial Corp is engaged in domestic banking services for individuals, businesses, municipalities and non-profit organizations. The bank has three operating segments; Banking segment provides financial services including a full range of banking services such as deposit taking, loan origination, and servicing, mortgage banking, other general banking services, and equipment lease financing, Wealth Management segment offers investment advisory, financial planning, trust and brokerage services, and The Insurance segment includes a full-service insurance brokerage agency offering commercial property and casualty insurance, employee benefits solutions, personal insurance lines and human resources consulting. It generates majority of its revenue from the banking segment.

Share on Social Networks: